477
Views
5
CrossRef citations to date
0
Altmetric
Reviews

‘Old' and ‘new' drugs for the treatment of cancer pain

, , , , , , , , & show all
Pages 425-433 | Published online: 25 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Laxmaiah Manchikanti, Kavita N. Manchikanti, Alan D. Kaye, Adam M. Kaye & Joshua A. Hirsch. (2018) Challenges and concerns of persistent opioid use in cancer patients. Expert Review of Anticancer Therapy 18:7, pages 705-718.
Read now

Articles from other publishers (4)

Umberto M. Musazzi, Carlo Matera, Clelia Dallanoce, Federica Vacondio, Marco De Amici, Giulio Vistoli, Francesco Cilurzo & Paola Minghetti. (2015) On the selection of an opioid for local skin analgesia: Structure-skin permeability relationships. International Journal of Pharmaceutics 489:1-2, pages 177-185.
Crossref
Rohit Juneja. (2014) Opioids and cancer recurrence. Current Opinion in Supportive & Palliative Care 8:2, pages 91-101.
Crossref
Angela Maria Sousa, José de Santana Neto, Gabriel M. N. Guimaraes, Giovana M. Cascudo, José Osvaldo B. Neto & Hazem A. Ashmawi. (2013) Safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series study. Supportive Care in Cancer 22:3, pages 795-801.
Crossref
Céline Algret, Michelle Pimont & Pierre Beaulieu. 2014. Mental Health and Pain. Mental Health and Pain 261 307 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.